"Natural" or Alternative Medications for Migraine Prevention
Park Nicollet Health Services, 6490 Excelsior Blvd, E-500, Minneapolis, MN 55426, USA. Headache The Journal of Head and Face Pain
(Impact Factor: 2.71).
07/2006; 46(6):1012-8. DOI: 10.1111/j.1526-4610.2006.00473.x
Available from: David Lester
- "Petasites hybridus is a European wild herb, and extracts of the roots are used for the treatment of pain. It seems to be effective in reducing migraine attack frequency if administered in doses > 50 mg bid.19 Petasites hybridus’s adverse effects are similar to those of a placebo. "
[Show abstract] [Hide abstract]
ABSTRACT: Migraine is a serious illness that needs correct treatment for acute attacks and, in addition, a treatment prophylaxis, since patients with migraine suffer during acute attacks and also between attacks.
A systematic review of the most relevant clinical trials of migraine headache and its epidemiology, pathophysiology, comorbidity, and prophylactic treatment (medical and nonmedical) was carried out using "Medline" and "PsychINFO" from 1973 to 2009. Approximately 110 trials met our inclusion criteria and were included in the current review.
The most effective pharmacological treatment for migraine prophylaxis is propranolol and anticonvulsants such as topiramate, valproic acid, and amitriptyline. Nonmedical treatments such as acupuncture, biofeedback, and melatonin have also been proposed. Peripheral neurostimulation has been suggested for the treatment of chronic daily headache that does not respond to prophylaxis and for the treatment of drug-resistant primary headache. The majority of the pharmacological agents available today have limited efficacy and may cause adverse effects incompatible with long-term use.
The review was limited by the highly variable and often insufficient reporting of the complex outcome data and by the fact that migraine prophylaxis trials typically use headache diaries to monitor the course of the disease. The results of the different studies were also presented in different ways, making comparison of the results difficult.
An adequate prophylaxis is crucial in reducing disability and preventing the evolution of the problem into a chronic progressive illness. The implications of the present findings were discussed.
Patient Related Outcome Measures 07/2010; 1:107-18. DOI:10.2147/PROM.S9742
Disease-a-Month 01/2008; 54(1-2):7-156. DOI:10.1016/j.disamonth.2007.10.002 · 0.95 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: The use of herbals and health supplements is not without risk. This case report of a 17-year-old girl who presented with acute dural sinus thrombosis following herbal tonic ingestion illustrates the dangers of unsupervised ingestion of "health supplements."
A 17-year-old girl with normal menses and no prior medical history, procoagulant risk factors, or oral contraceptives use, presented following ingestion of herbal liquid for 2 days, with signs and symptoms of dural sinus thrombosis confirmed by CT scan. MRI and MRV showed bilateral transverse sinuses thrombosis. The patient had an extensive workup, and all procoagulant disorders or factors, including Behcet's disease, were ruled out. The temporal profile of the ingestion of herbal fluid may suggest association with the development of sinus thrombosis.
Combinations of herbs in dietary or health supplements could potentiate their subclinical procoagulant effects, and this case highlights the need to report such serious central nervous system adverse effects associated with the ingestion of herbal preparations.
Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 09/2007; 16(5):232-5. DOI:10.1016/j.jstrokecerebrovasdis.2007.06.003 · 1.67 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.